# The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma

> **NCT06150144** · PHASE3 · UNKNOWN · sponsor: **University of Aleppo** · enrollment: 40 (estimated)

## Conditions studied

- Basal Cell Carcinoma
- BCC

## Interventions

- **DRUG:** 5-Fluorouracil
- **OTHER:** SURGERY

## Key facts

- **NCT ID:** NCT06150144
- **Lead sponsor:** University of Aleppo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-25
- **Primary completion:** 2025-05-25
- **Final completion:** 2025-05-25
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06150144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06150144, "The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06150144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*